Stephanie Lee, M.D.

Stephanie Lee, M.D.


Hospice and Palliative Medicine

Internal Medicine


Internal Medicine


  • Associate Physician


Stephanie Lee is not currently accepting new patients. For assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Philosophy of Care

Recognizing that the effects of illness extend far beyond the physical, I use a holistic approach to patient care. I provide compassionate care to the whole patient by providing physical, emotional, and spiritual support with the goal of helping patients achieve the best possible quality of life. 

Clinical Interests

Dr. Lee collaborates with a multidisciplinary team in order to help care for hospitalized adult patients facing serious illnesses.

Her interests include hospice and palliative Medicine, and medical education.


Pulmonary, Critical Care, and Sleep Medicine


M.D., Geisel School of Medicine at Dartmouth, New Hampshire, 2013

B.S., Computer Science, Brown University, Rhode Island, 2005


Internal Medicine, UC Irvine Medical Center, 2013-2016


Hospice and Palliative Medicine, UC Davis Medical Center, 2017-2018

Board Certifications

American Board of Internal Medicine,

Select Recent Publications

Ortizo R, Lee SY, Nguyen ET, Jamal MM, Bechtold MM, Nguyen DL. Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease: A meta-analysis of case-controlled and cohort studies. Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1064-1070. PMID: 28542115.

Lee SY, Jamal MM, Nguyen ET, Bechtold ML, Nguyen DL. Does exposure to isotretinoin increase the risk for the development of inflammatory bowel disease?: A meta-analysis. Eur J Gastroenterol Hepatol. 2016 Feb;28(2):210-6. PMID: 26545085.

Lee SY, Bechtold ML, Jamal MM, Nguyen DL. “Quality of Life and Caregiver Burden Among Caregivers of Patients with Chronic Liver Disease.” Caregivers: Practices, Challenges and Expectations. Ed. Adrienne Lloyd. New York: Nova Science Publishers Inc., 2015.

Rosas HD, Reuter M, Doros G, Lee SY, et al. A tale of two factors: What determines the rate of progression in Huntington’s disease? A longitudinal MRI study. Mov Disord. 2011 Aug 1;26(9):1691-7. PMID: 21611979.

Rosas HD, Lee SY, Bender AC, et al. Altered white matter microstructure in the corpus callosum in Huntington’s disease: Implications for cortical “disconnection”. NeuroImage. 2010 Feb 15;49(4):2995-3004. PMID: 19850138.

Salat DH, Tuch DS, van der Kouwe AJW, Greve DN, Pappu V, Lee SY, Hevelone ND, Zaleta AK, Growdon JH, Corkin S, Fischl B, Rosas HD. White matter pathology isolates the hippocampal formation in Alzheimer’s disease. Neurobiology of Aging. 2010 Feb;31(2):244-56. PMID: 18455835.

Salat DH, Lee SY, Setty B, Rosas HD, Grant PE. “Diffusion imaging in development and aging.” Diffusion MRI: From quantitative measurement to in-vivo neuroanatomy. 1st ed. Ed. Johansen-Berg H and Behrens TEJ. London: Academic Press; 2009:205-236.

Salat DH, Lee SY, van der Kouwe AJ, Greve DN, Fischl B, Rosas HD. Age-associated alterations in cortical gray and white matter signal intensity and gray to white matter contrast. NeuroImage. 2009 Oct 15;48(1):21-8. PMID: 19580876.

Rosas HD, Salat DH, Lee SY, Zaleta AK, Hevelone N, Hersch SM. Complexity and heterogeneity: What drives the everchanging brain in Huntington’s disease? Ann N Y Acad Sci. 2008 Dec;1147:196-205. Review. PMID: 19076442.

Rosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischl B, Greve B, Hevelone N, Hersch SM. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 2008 Apr;131(4):1057-1068. PMID: 18337273.